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Abstract
The role of glycosphingolipids (GSLs) present in amastigote forms of
Leishmania (Leishmania) amazonensis during infection of macro-
phages was analyzed, with particular emphasis on GSLs presenting
the terminal Galpß1-3Galpα disaccharide. Macrophage invasion by
L. (L.) amazonensis amastigotes was reduced by 37% when the
disaccharide Galpß1-3Galp (1 mM) was added to the culture medium.
The putative macrophage receptor/lectin for ß-Gal-globotriaosylcera-
mide (Galpß1-3Galpα1-4Galpß1-4Glcpß1-1Cer) and other structur-
ally related GSLs from L. (L.) amazonensis amastigotes were ana-
lyzed by micelles and parasite binding assay to peritoneal macrophage
proteins fractionated by SDS-PAGE under nonreducing conditions.
Micelles containing purified amastigote GSLs or a suspention of L.
(L.) amazonensis amastigotes fixed with 2% formaldehyde were
incubated with nitrocellulose membrane containing the macrophage
proteins transferred by Western blotting. Binding of micelles contain-
ing purified GSLs from amastigote forms or fixed L. (L.) amazonensis
amastigotes to nitrocellulose membrane was probed using monoclon-
al antibody ST-3, which recognizes the glycoepitope Galpß1-3Galpα1-
R present either in the micelle preparation or on the amastigote
surface. Macrophage protein with molecular mass ~30 kDa bound the
amastigote GSL and appeared to be a doublet on electrophoresis. The
specificity of this interaction was confirmed using fixed L. (L.)
chagasi amastigotes, which do not express GSLs such as ß-Galp-
globotriaosylceramides, and which do not bind to 30-kDa protein.
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Introduction
Species of the genus Leishmania (family
Trypanosomatidae) are protozoans respon-
sible for a variety of human diseases, includ-
ing cutaneous, mucocutaneous, and visceral
leishmaniasis, which occur throughout the
world and represent a major public health
problem in tropical areas. Leishmania is a
digenetic parasite with extracellular motile
promastigotes present in the alimentary tract
of their insect vector, the phlebotomine
sandfly, and intracellular non-motile amasti-
gotes, which live in the mononuclear phago-
cytes of mammalian hosts. The etiologic
agents of leishmaniasis include many com-
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plex and epidemiologically diverse Leish-
mania species. Leishmania (Leishmania)
amazonensis is responsible for most of the
cases of human cutaneous leishmaniasis in
the Amazon region of Brazil (1).
Leishmania phagocytosis has been stud-
ied in detail in promastigotes of various
species (2). The promastigote-macrophage
interaction is a multi-step phenomenon me-
diated mainly by the protease gp63 and lipo-
phosphoglycan (3-6). A number of studies
have identified macrophage receptors in-
volved in the process of Leishmania inva-
sion, including mannose-fucose receptor,
receptors for advanced glycation end prod-
ucts, fibronectin, complement receptor (CR1
and CR3), and Fc receptor (2).
In contrast to abundant information avail-
able on phagocytic processes of promasti-
gote forms, few studies have been conducted
on phagocytic processes of amastigote forms,
which are responsible for maintaining and
disseminating infection in the vertebrate host
(2,7). Previous studies on the biological roles
of Leishmania glycosphingolipid (GSL)
antigens demonstrated that monoclonal
antibodies (mAbs) ST-3, ST-4 and ST-5,
specifically directed at amastigote L. (L.)
amazonensis GSLs, inhibited macrophage
invasion by amastigotes by as much as 80%,
suggesting that the epitope recognized by
these mAbs present in surface GSLs is
important in mediating binding of L. (L.)
amazonensis amastigotes to macrophages
(8,9).
To better characterize the biological role
of stage-specific GSLs, in particular the role
of the terminal disaccharide Galpß1-3Galp,
present in L. (L.) amazonensis amastigote
GSL antigens such as Galpß1-3Galpα1-
4Galpß1-4Glcpß1-1Cer (referred to herein
as ß-Gal-globotriaosylceramide), we per-
formed macrophage infection assays using
different glycosides as inhibitors. mAb ST-3
was used to evaluate binding of amastigotes
and micelles containing amastigote GSLs to
specific receptors in macrophages.
Material and Methods
Parasites
Amastigote forms of L. (L.) amazonensis
(MHOM/BR73/M2269) were maintained by
footpad infection of Golden hamsters or
BALB/c mice. Amastigotes (2 x 107) were
inoculated into hamster footpads and the
lesions were surgically removed after 5-6
weeks. Tissue was minced in phosphate-
buffered saline (PBS) and debris were elimi-
nated by nylon Nitex filtration (pore size, 80
µm; Tekto, Monterey Park, CA, USA). The
cell suspension was centrifuged at 1800 g
for 10 min. To lyse erythrocytes, the pellet
was resuspended in ammonium chloride so-
lution (8.29 g NH4Cl, 1 g KHCO3, 37.3 mg/
L EDTA) for 10 min, and the insoluble
material containing infected macrophages
was disrupted in a Dounce-Potter homog-
enizer with about 20 strokes. The resulting
suspension was centrifuged four times at
1800 g, and the final pellet was resuspended
in RPMI 1640. The suspension was shaken
for 3 h and the amastigotes were washed
with PBS four times by centrifugation at
1800 g. The parasite yield was 5 x 109 amas-
tigotes/hamster.
Amastigotes of L. (L.) chagasi (MHOM/
BR72/LD) were maintained by intraperito-
neal inoculation in Golden hamsters. Two
months after infection, spleens were removed
and homogenized, and amastigotes were iso-
lated as described by Pinto et al. (10).
All experimental animal procedures were
approved by the Institutional Ethics Com-
mittee.
Hybridomas and sera
Monoclonal antibodies ST-3 (mouse
IgG3) directed to L. (L.) amazonensis GSLs
(8) and CU-1 (mouse IgG3), directed to the
Tn antigen (11) and used as an irrelevant
antibody, were obtained from the culture
supernatant. Sera of patients with visceral
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leishmaniasis (1:200 dilution) were tested
by indirect immunofluorescence with L. (L.)
chagasi amastigotes before use. Amastigotes
fixed with 1% formaldehyde were submitted
to indirect immunofluorescence as described
by Straus et al. (8).
Purification of glycosphingolipids
Amastigote GSLs were extracted and
purified as described by Straus et al. (8).
Amastigotes (2 x 1011) were homogenized in
30 mL isopropyl alcohol/hexane/water (55:
20:25) and in 30 mL chloroform/methanol
(2:1). The extracts were combined and dried
in a rotary evaporator. The resulting “lipid
fraction” contained sterols, phospholipids,
and glycolipids. GSLs were purified from
this lipid fraction by Florisil chromatogra-
phy (12). Briefly, the lipid fraction was dried,
treated with pyridine/acetic anhydride (2:1),
and acetylated GSLs were separated from
other lipids on a Florisil column. Nonpolar
lipids were first eluted with 1,2-dichloroeth-
ane, and then acetylated GSLs were eluted
with 1,2-dichloroethane/acetone (1:1). The
GSL fraction was diacetylated with 0.5%
sodium methoxide in methanol, neutralized
with Dowex 50 (H+ form), and subjected to
DEAE-Sephadex ion exchange chromatog-
raphy in chloroform/methanol/water 30:60:8
(13). Neutral GSLs were further subjected to
HPLC on Iatrobeads column (4.6 x 300 mm,
6RS-8010; Iatron, Tokyo, Japan) and eluted
with a gradient of isopropyl alcohol/hexane/
water from 55:44:3 to 55:30:25 over 175
min, with a flow rate of 1 mL/min (fractions
of 2 mL). GSLs were identified by HPTLC
using solvent A (chloroform/methanol/aque-
ous CaCl2 0.02%, 60:40:9), stained with or-
cinol/H2SO4 (14). Fractions 3 to 10 (eluted
from 3.7 to 5.5% water) contained mono-
hexosylceramide (CMH), dihexosylceramide
(CDH), and trihexosylceramide (CTH). Frac-
tions 11 to 55 (eluted from 5.7 to 13.8%
water) corresponded to GSLs with 4 or more
carbohydrate residues, and were recognized
by mAb ST-3. No contamination with lipo-
phosphoglycan, phospholipids or peptides
was detected, as described previously (8,15).
Peritoneal macrophage culture
Macrophages were harvested by wash-
ing the peritoneal cavity of BALB/c mice
with PBS, and cultivated in RPMI 1640
supplemented with 10% fetal calf serum
(FCS). Approximately 5 x 105 macrophages
were placed on sterile glass coverslips in 24-
well plates, or about 5 x 107 cells were placed
in a 150-cm2 tissue culture flask. Non-adher-
ent cells were removed by several washes
with RPMI 1640, and the plates kept at 37ºC
in a CO2 incubator.
Alternatively, thioglycolate-elicited peri-
toneal macrophages of BALB/c mice were
harvested 4 days after intraperitoneal thio-
glycolate inoculation (1.0 mL of 3% thiogly-
colate in PBS).
Glycoside inhibition of Leishmania uptake
into macrophages
Fifty microliters of a 10-mM solution of
the following glycosides: methyl α-D- and
ß-D-galactopyranoside, ß-lactose (Galpß1-
4Glc), Galpß1-3Galpß 1-OMe (all from
Sigma, St. Louis, MO, USA), and Galpß1-
3Galp obtained by partial acid hydrolysis of
native vegetal polysaccharide from Anacar-
dium occidentale (16) was added to wells
containing 0.45 mL RPMI 1640 and ~5 x 105
macrophages. After 1 h, parasites were added
(2.5 x 105 per well) and maintained for 2 h in
RPMI 1640 without FCS at 37ºC. Nonad-
herent parasites (less than 10% of total added
amastigotes) were removed, and cultures
were maintained in RPMI 1640 with 5%
FCS in a CO2 incubator for 24 h. Macro-
phages were fixed with methanol and stained
with the Hema 3 Stain Set (Fisher, Swedes-
boro, NJ, USA). The percent of macrophages
that had phagocyted at least one parasite was
determined by examining 300 cells, as de-
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scribed by Silveira et al. (17).
Western blotting
About 1 x 107 macrophages harvested
from tissue culture flasks were homogenized
with 1.0-mL sample buffer. Aliquots (20 µL)
were separated by SDS-PAGE into 5 x 12
mm lanes of 8.0 or 12% polyacrylamide slab
gels (80 x 60 mm) under non-reducing con-
ditions, and transferred onto nitrocellulose
(Gibco-BRL, Grand Island, NY, USA). The
nitrocellulose was blocked with 5% BSA in
PBS for 2 h, incubated with parasites or
GSL-containing micelles as described be-
low, and then sequentially incubated with
mAb ST-3, biotin-conjugated goat anti-
mouse IgG, peroxidase-conjugated avidin,
and 4-chloro-naphthol (18).
Glycosphingolipid micelle and parasite
binding assays
The blotted nitrocellulose membrane
blocked with BSA was incubated for 45 min
at room temperature with purified amasti-
gote GSL (type I micelles), and total amasti-
gote lipid fraction (type II micelles) pre-
pared by ultrasonication (Branson 2200,
VWR Scientific, Danbury, CT, USA) of gly-
colipids (450 µg carbohydrate in 3.0 mL
RPMI 1640) for 45 s (19), or with a suspen-
sion of amastigotes (1 x 108 parasites in 3.0
mL RPMI 1640 medium) fixed with 2%
formaldehyde in PBS for 10 min. Binding of
parasites or GSL micelles was visualized
after immunostaining with mAb ST-3.
Labeling of macrophage surface proteins with
biotin
Peritoneal macrophages (1 x 107 cells)
were washed twice with PBS and incubated
with 0.1 mg/mL biotin sulfo n-hydroxysuc-
cinimide (Sigma) in PBS for 20 min at 4ºC.
The reaction was stopped by washing the
cells with cold PBS. Excess biotin was
blocked by incubation with PBS containing
1% BSA for 20 min at 4ºC, followed by one
wash with PBS. Cells were homogenized
with 0.5% Triton X-100 (Sigma) in PBS
containing 1 mM phenylmethylsulfonyl fluo-
ride (PMSF) (Sigma) and 1 µM leupeptin
(Sigma) and centrifuged at 12,000 g. Triton
X-100-soluble (1.0 mL) and -insoluble (re-
suspended in 1.0 mL of sample buffer) frac-
tions were separated by SDS-PAGE and
transferred to nitrocellulose. Biotinylated
proteins were visualized after incubation of
nitrocellulose with peroxidase-conjugated
avidin and 4-chloronaphthol.
Isolation of macrophage soluble protein and
membrane fractions
Peritoneal macrophages (1 x 107 cells)
biotinylated or not were resuspended in PBS
(1.0 mL) and lysed by three cycles of freez-
ing and thawing in PBS containing 1 mM
PMSF and 1 µM leupeptin. The lysate was
centrifuged at 12,000 g for 10 min and the
soluble proteins (supernatant) and insoluble
membrane fraction (pellet) were subjected
to Western blotting and to parasite binding
assays, as described above.
Results
Effect of glycosides on macrophage infectivity
by L. (L.) amazonensis amastigotes
In order to identify the biological role of
specific glycan structures expressed in GSLs
of amastigote forms of L. (L.) amazonensis
in the interaction with macrophages, we pre-
incubated peritoneal macrophage cultures
with various glycosides and then tested them
for amastigote infectivity. Among the gly-
cosides tested the most effective infectivity
inhibitor was Galpß1-3Galp (Table 1). The
number of infected macrophages decreased
by about 37% when macrophages were pre-
incubated with Galpß1-3Galp (1 mM), indi-
cating that this disaccharide, present at the
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non-reducing terminus of ß-D-Gal-globotri-
aosylceramide, which is recognized by mAb
ST-3, is involved in parasite infectivity.
Galpß1-3Galp inhibition was clearly dose
dependent, as shown in Figure 1.
Binding of purified glycolipids and
amastigotes to macrophage (glyco)proteins
Resident peritoneal mouse macrophage
components were fractionated by SDS-
PAGE and micelle binding to nitrocellulose
membranes was probed using mAb ST-3.
Binding experiments were performed using
two types of micelles, type I containing pu-
rified amastigote GSLs and type II contain-
ing amastigote total lipid extract (GSLs, phos-
pholipids and sterols), to mimic glycolipid
organization in the parasite membrane. Both
type I and type II micelles bound to a ~30-
kDa molecule (Figure 2A, lanes 1 and 2,
arrow). To rule out the possibility that GSLs
with one, two, or three carbohydrate resi-
dues present in the micelle preparation were
responsible for the binding, GSL fractions
containing only CMH (GlcCer), CDH
(Galß1-4GlcCer) and CTH (Galα1-4Galß1-
4GlcCer) purified by HPLC as described in
Material and Methods were incubated with a
nitrocellulose membrane and, as expected,
no mAb ST-3 labeling was observed (lane
3). However, when this nitrocellulose mem-
brane was subsequently exposed to type I
micelles, labeling by mAb ST-3 of the 30-
kDa component was again detected (lane 4).
No reactivity with the 30-kDa component
was detected when an irrelevant mAb (CU-
1) was used to detect binding of type I micelles
to the nitrocellulose membrane (lane 5).
The macrophage 30-kDa component was
also visualized in a binding assay using fixed
L. (L.) amazonensis amastigotes instead of
GSL micelles, confirming that the amasti-
gotes also bind to the 30-kDa protein (Figure
2B, lane 1). No labeling was observed using
an irrelevant antibody (lane 2). It is notewor-
thy that this 30-kDa protein was not recog-
nized by L. (L.) chagasi amastigotes (lane
3).
Micelle binding to the macrophage
membrane fraction
To further determine if the 30-kDa pro-
tein is associated with the macrophage mem-
brane, and to analyze the possibility that
galectin-3, a macrophage soluble protein, is
associated with parasite binding to macro-
phages, resident and thioglycolate-activated
peritoneal macrophages, the latter express-
ing large amounts of galectin-3, were iso-
lated from the peritoneal cavity of mice and
plated. After 24 h the culture medium was
removed and the cells were collected from
the culture plates with a minimum volume of
PBS and disrupted by a freezing/thawing
procedure. The resulting suspensions were
centrifuged at 12,000 g and the supernatant
(containing galectin-3 and other soluble pro-
teins) and pellet (membrane fraction) were
fractionated by SDS-PAGE. Amastigotes
bound exclusively to the region of the 30-
Table 1. Inhibition by glycosides of macrophage
infectivity by Leishmania (Leishmania) amazo-
nensis amastigotes.
Glycoside (1 mM) Macrophages infected
with Leishmania (%)
Methyl ß-D-Galp 44.33 ± 2.52
Methyl α-D-Galp 37.00 ± 4.58
Galpß1-3Galp 27.50 ± 2.74*
Galpß1-3Galpß1-O-methyl 45.67 ± 1.15
Galpß1-4Glcp 36.30 ± 5.07
Control 43.67 ± 8.14
Macrophages were pre-incubated with various
glycosides for 1 h and the parasites were then
added and maintained for 2 h. Non-adherent para-
sites were removed. After 24 h, infected macro-
phages were fixed with methanol and stained,
and the percentage of infected macrophage was
determined as described in Material and Meth-
ods. Control macrophage cultures were not pre-
incubated with any glycoside before parasite in-
fection. Data are reported as means ± SD of
triplicate experiments.
*P < 0.05 compared to control (Student t-test).
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kDa proteins present in the pellet (corre-
sponding to the membrane fraction), visual-
ized as a doublet in a 12% gel slab (Figure 3,
lane M). No difference in the amastigote
binding pattern was observed between resi-
dent (Panel A) and thioglycolate-elicited
(Panel B) peritoneal macrophages, a fact
ruling out the possibility that galectin-3 is
involved in the parasite-macrophage inter-
action modulated by GSLs.
Macrophage surface labeling
Cultured macrophages were tagged with
biotin at 4ºC for surface protein labeling.
Cells were removed from the plates and
processed as described in Material and Meth-
ods. The fractions that were soluble (S) and
insoluble (I) in 0.5% of Triton X-100 were
analyzed for total protein content and stained
with Coomassie blue (Figure 4A). Biotinyl-
ated proteins were identified by Western
blotting revealed with peroxidase-conjugated
avidin and 4-chloro-naphthol (Figure 4B).
Major label proteins were present in the
soluble fraction (lane S). On the other hand,
the doublet of 30 kDa was the only biotinyl-
ated protein that remained in the insoluble
fraction (panel B, lane I). Panel C shows that
the macrophage doublet of 30 kDa recog-
nized by amastigotes remained in the in-
soluble fraction of 0.5% Triton X-100 (Panel
4C, lane I).
Discussion
The numerous roles of macrophage in
host defense may be reflected in the variety
of lectins present in these cells. Some of
them (e.g., mannose receptor, CR3) partici-
pate in microbial phagocytosis, while others
are involved in cell adhesion, clearance, re-
cruitment, or activation (20). Our laboratory
recently demonstrated that glycosylinositol
phospholipid-1 of L. (L.) major and its ter-
minal residue, ß-D-galactofuranose, partici-
pate in the interaction of L. (L.) major pro-
Figure 1. Macrophage infectivity
by Leishmania (Leishmania)
amazonensis amastigotes in the
presence of various concentra-
tions of Galpß1-3Galp glyco-
side. Macrophages were incu-
bated with Galpß1-3Galp for 1 h
and then infected with L. (L.)
amazonensis amastigotes for 2
h at 37ºC. Non-adherent para-
sites were removed and infected
macrophages were maintained in a CO2 incubator for 24 h. The percent of infected
macrophages was calculated as described in Material and Methods. Control macrophages
were incubated without Galpß1-3Galp. Data are reported as means ± SD of triplicate
experiments. *P < 0.05 compared to control (Student t-test).
Figure 2. Binding of fixed Leish-
mania (Leishmania) amazonen-
sis amastigotes and purified
glycosphingolipids (GSLs) to
mouse peritoneal macrophage
proteins. Lysate macrophages
were processed and samples
containing about 10 µg protein
were applied to each SDS-
PAGE lane and transferred to a
nitrocellulose (NC) membrane.
A, Binding of micelles contain-
ing lipids and GSL antigens. Lane 1, NC incubated with type II micelles (containing total
amastigote lipids); lane 2, NC incubated with type I micelles (purified amastigote GSLs);
lane 3, NC incubated with micelles containing monohexosylceramide (CMH), dihexosylcer-
amide (CDH), and trihexosylceramide (CTH), purified from amastigotes; lane 4, NC pre-
incubated with micelles containing CMH, CDH, and CTH, followed by incubation with type I
micelles; lane 5, NC incubated with type I micelles immunostained with an irrelevant
antibody (mAb CU-1). Micelle binding was detected after incubation with mAb ST-3. B,
Binding of formaldehyde-fixed amastigotes. Lane 1, L. (L.) amazonensis amastigotes
immunostained with ST-3; lane 2, binding of L. (L.) amazonensis amastigotes immuno-
stained with CU-1; lane 3, binding of L. (L.) chagasi amastigotes immunostained with sera
positive for visceral leishmaniasis. The arrows indicate the 30-kDa component recognized
by either L. (L.) amazonensis amastigotes or amastigote GSL micelles.
Figure 3. Binding of amasti-
gotes to soluble proteins and to
the membrane fraction of peri-
toneal macrophages. Resident
(Panel A) and thioglycolate-
elicited (Panel B) peritoneal
macrophages were resus-
pended in PBS and subjected
to a freezing/thawing procedure
as described in Material and
Methods. Soluble (S) proteins
(about 10 µg protein/lane) and
insoluble membrane (M) prepa-
rations (about 10 µg protein/
lane) were fractionated by SDS-PAGE using 12% gel slabs, transferred to nitrocellulose
membranes and assayed for binding of formaldehyde-fixed amastigotes immunostained
with ST-3. The arrows indicate the 30-kDa doublet recognized by Leishmania (Leishmania)
amazonensis amastigotes.
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mastigotes and amastigotes with mouse peri-
toneal macrophages (21), but not to interac-
tions of other species such as L. (L.) amazo-
nensis. On the other hand, in indirect experi-
ments where Fab fragments of mAb ST-3,
directed specifically to amastigote GSLs,
significantly inhibited macrophage infectiv-
ity (8), we have shown that L. (L.) amazo-
nensis amastigote GSLs, in addition to mod-
ulating the host cell immune response (14,
22), play a role in macrophage infectivity.
In the present study, we demonstrated
that the disaccharide Galpß1-3Galp, whose
reducing terminus is not substituted at the
anomeric carbon, presents in solution alpha
(Galpß1-3Galpα) and/or beta (Galpß1-
3Galpß) isomers and inhibits invasion of
macrophage cells by L. (L.) amazonensis
amastigotes by ~37%. In contrast, the disac-
charide Galpß1-3Galpß1-O-methyl, which
has the subterminal galactose locked in a
beta configuration, did not inhibit macro-
phage infectivity. These results clearly indi-
cate the key role of the anomeric configura-
tion of the subterminal galactose unit in the
parasite binding to macrophages. Thus, the
inhibition of the macrophage infectivity by
amastigote forms observed with Galpß1-
3Galp is related to the presence of the Galpß1-
3Galp isomer, whereas the Galpß1-3Galpß
isomer does not bind the 30-kDa protein/
receptor.
Using mAb ST-3, which recognizes ß-
Galp-globotriaosylceramide and related
amastigote GSLs, we analyzed the putative
receptor/lectin of macrophages for these
GSLs. By Western blotting of a macrophage
preparation, we identified a single band with
a molecular mass of 30 kDa using micelles
prepared with highly purified amastigote
GSLs. No inhibition was observed when
nitrocellulose was pre-incubated with CMH,
CDH, and CTH purified from Leishmania
preparations. The same protein was identi-
fied when the nitrocellulose sheet was incu-
bated with fixed L. (L.) amazonensis amasti-
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Figure 4. Macrophage surface protein labeling with biotin. Macrophage cultures were labeled
with biotin sulfo n-hydroxysuccinimide at 4ºC as described in Material and Methods. The
labeled cells were incubated with 0.5% Triton X-100 and the soluble (S) and insoluble (I)
fractions obtained after centrifugation were separated by SDS-PAGE using 12% gel slab (S,
10 µg protein/lane; I, 1.2 µg protein/lane). Panel A, SDS-PAGE of biotinylated macrophage
proteins stained with Coomassie blue. Panel B, Western blotting of biotinylated macrophage
proteins visualized after nitrocellulose incubation with peroxidase-conjugated avidin, and 4-
chloro-naphthol. Panel C, Binding of formaldehyde-fixed amastigotes to nitrocellulose con-
taining 0.5% Triton X-100 soluble and insoluble fractions. The arrows indicate the 30-kDa
doublet recognized by Leishmania (Leishmania) amazonensis amastigotes.
gotes. However, when the nitrocellulose sheet
was incubated with fixed L. (L.) chagasi
amastigotes, which do not express GSLs
such as ß-Galp-globotriaosylceramides, no
labeling of the 30-kDa protein was detected.
The 30 kDa-protein detected by PAGE-
SDS using an 8% acrylamide gel slab is
resolved as a doublet in a 12% acrylamide
gel slab and is recognized by L. (L.) amazo-
nensis amastigotes in SDS-PAGE carried
out under reducing or not-reducing condi-
tion (data not shown). The 30-kDa doublet
protein recognized by L. (L.) amazonensis
amastigotes and its GSLs i) is present on the
macrophage surface as demonstrated by
macrophage biotin labeling, ii) is insoluble
in 0.5% Triton X-100, and iii) is recognized
by concanavalin A (data not shown), indi-
cating that this receptor is a glycoprotein.
These data, taken together with the fact that
the 30-kDa putative receptor is not detected
in the culture medium and its expression is
not altered by macrophage activation with
thioglycolate, rule out the possibility that
this molecule could correspond to galectin-
3. The amino acid sequence of the 30-kDa
receptor is currently under investigation.
A B C
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